The alliance between the industry giants have always contributed in the growth of the market. Recently, same trend is witnessed by the implantable biomaterial industry in the Europe.
It was announced by B. Braun, a German company that it would merge with Christie Medical Holding Inc. The companies aim to improve the Peripheral Intravenous (IV) access. The IV therapy continues to be a significant medical intervention in patient care. It has been observed that about 90% of the patients in hospitals receive this therapy in their course of treatment. Several hospitals have started to adopt the technology in the therapy for improvement in duration, safety, and placement. The integration of therapy by B. Braun and Christie goals to provide an advanced solution to boost success of the peripheral IV catheter access. The therapies provided by B. Braun includes the Wedge™ catheter stabilizer along with STEADYCare™ extension set and the Introcan Safety® IV catheter. Christie would provide with a technology by the name of VeinViewer.
Request sample report @ http://bit.ly/2pMCX0j
The advancement of technology made by the firm in VeinViewer claims to reduce the time required for insertion of IV. In addition, it would improve success rate of the first stick when the therapists start with an IV catheter. This eventually improves experience of the patient. The VeinViewer technology permits nurses to clearly perceive peripheral veins in high definition image and real-time right at the skin of the patient. The hospitals with the help of VeinViewer technology have recognized the advantages to obtain peripheral IV access. It is reported by the experts that with the use of technology, there has been decrease in application of central lines. This has led to increase in cost savings by the hospitals.
The Introcan Safety IV catheter by B. Braun supplements system of the VeinViewer. The safety catheter provides an inert safety with assistance of an advanced solution, which aims to cure injuries of accidental needlestick. Furthermore, STEADYCare extension set with Wedge catheter stabilizer by B. Braun is designed in such a way that it helps to minimize movement off the catheter in the vessel. It supports angle of the catheter insertion and decreases the contact of connectors with skin of the patient. This helps to reduce the complication related to the catheter. In addition, the Christie would continue to offer the educational programs as given in the programs of Christie Assure, which includes tele-training, Christie University, and Assure Clinical Educators.
The merger would benefit the consumers as they would get better treatment with the help of technology. This would assist investors to identify the new market trends. This, in turn would ensure the progress path of the implantable biomaterial industry as mentioned in the report added by Big Market Research, titled, “Europe Implantable Biomaterial Market Research Report Forecast 2017–2021”.
Ask for discount @ http://bit.ly/2pM0Oez
About Company :
Big Market Research uniqueness lies in its highly ethical reports at economical rates because we value your relationship and growth more than money. Your growth is our aim. With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.
Contact Us :
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
Direct :+ 1-503-894-6022
Toll Free : + 1-800-910-6452